47 results about "Opportunistic pathogen" patented technology

The invention discloses lactobacillus jensenii and application thereof. The lactobacillus jensenii is particularly lactobacillus jensenii IMJ-1, and the file No. of the lactobacillus jensenii IMJ-1 in the General Microbiological Culture Collection Center of China Microbial Culture Collection Management Committee is CGMCC No. 6558. The lactobacillus jensenii IMJ-1 CGMCC No.6558 has high H2O2 generation capability, can effectively suppress breeding of external pathogenic bacteria and other conditional pathogenic bacteria, and has a high binding function to epithelial cells of vagina, and accordingly, breeding of bacteria strains on the vaginal epithelium is guranteed. Besides, the lactobacillus jensenii IMJ-1 CGMCC No. 6558 has a certain application prospect in preventing and curing bacterial vaginosis.

The invention provides a probiotic chewing gum preparation method. By means of a probiotic embedding technology, survivability of probiotics in chewing gum is kept, and long-time storage is facilitated; by means of the characteristic of long chewing gum chewing time, retention time of probiotics in the oral cavity is prolonged; furthermore, the characteristic that the probiotics can antagonize pathogenic bacteria is utilized to inhibit and kill opportunistic pathogens in the oral cavity; finally, the purposes of preventing and treating oral diseases of ozostomia, pulpitis, periapical periodontitis, gingivitis, periodontitis, acute necrotic ulcerative periodontitis, stomatitis and the like are achieved. In addition, the probiotics can enter gastrointestinal tracts along with saliva to promote host gastrointestinal tract flora health and has recovering and treating effects on symptoms of unacclimatization, anorexia, diarrhea and the like of flora disorder diseases.

The invention discloses lactobacillus crispatus Lcr-MH175 for preventing and treating female urogenital tract infection. The preservation number of the Lcr-MH175 is CGMCC No. 15938. The lactobacilluscrispatus Lcr-MH175 provided by the invention has relatively strong antibacterial ability, can effectively inhibit growth of external pathogenic bacteria and pathogenic bacteria under other conditions, and also has a relatively strong adhesion effect on Hela cells so as to ensure the colonization of the strain on vaginal epithelium. The lactobacillus crispatus Lcr-MH175 provided by the invention has a certain application prospect in the aspect of urogenital tract infection prevention and treatment.

A biological control is disclosed for termites, including subterranean termites such as C. formosanus, comprising a mixture of a chitin synthesis inhibitor such as lufenuron with a pathogen or opportunistic pathogen. The combination greatly enhances the effectiveness above that of the individual components. For example, P. aeruginosa is commonly found in association with termites, but it is not normally harmful to termites. However, in the presence of lufenuron, P. aeruginosa becomes an opportunistic pathogen that kills termites. As another example, B. thuringiensis, which otherwise has shown only limited effectiveness against termites, has greatly enhanced lethality in combination with lufenuron. In another aspect a termite toxicant is administered to termites in a clay-based bait. Clay acts as an attractant for subterranean termites such as C. formosanus, and a clay bait can increase a colony's consumption of a toxicant.

The invention provides a raw water after-treatment method in an aquatic breeding plant in summer and autumn, aiming at the conditions of high bacteria density, high sulfide content and high ammonia nitrogen content in raw water in the aquatic breeding plant in summer and autumn. With the adoption of ferrate pretreatment and hydrogen persulfate matched treatment, the amount of the hydrogen persulfate is reduced, and the sterilization effect of the ferrate is enhanced. According to the water treated by the method disclosed by the invention, the number of pathogenic bacteria in the water condition is 103 bacteria per ml or below, the sulfide content is in a safe concentration range, and when the water is used for breeding, the seed quality and the survival rate of the aquatic breeding plant can be obviously improved, the dependence on antibiotics in the breeding and cultivating link is alleviated or avoided, and the edible security of cultured products is effectively guaranteed.

The invention relates to a bacilli, its compound preparation and the preparing method for the compound preparation. Its name is Bacillus subtilis LY-35, which is preserved in the general microbe center of Micro Germ conservation Management committee of China, and its conservation number is:CGMCC N0.1222. The preparation is a mixture of lambda phage of culture of bacilli and staphylococcus, streptococcus, colibacillus, bacillus proteus, pseudomonad, salmonella, pasteurella and klebsiella, can cure and prevent all kinds of illness caused by conditional pathogen,is a micro biological preparation which can be used by being mixed with antibiotics or replace antibiotics without any remainder and pollution, with good curative effect and safety.

The invention discloses a method for detecting a target gene through multi-crossover constant-temperature amplification and nano-biosensing (MCDA-LFB), which can simultaneously detect specific genes IS6110 and IS1081 of a mycobacterium tuberculosis complex (MTBC). The invention also discloses a specific primer combination which aims at the two genes and is applied to the method. The whole MCDA amplification can be completed within 30 minutes by the multi-crossover constant-temperature amplification method, the detection range for the two genes is 10 ng to 10 fg, and accordingly, extremely highsensitivity is achieved; only members belonging to the MTBC can have positive results through MTBC-MCDA-LFB tests, non-specific amplification of other common pathogens and opportunistic pathogens does not occur, and accordingly, the method has extremely high specificity.

The invention discloses a medical humidification liquid having a bacteriostasis function and relates to the medical field. The medical humidification liquid having a bacteriostasis function comprises epsilon-polylysine and distilled water, wherein 0.01 to 0.5g of epsilon-polylysine is added into each 100ml of distilled water. The medical humidification liquid having a bacteriostasis function also comprises a bacteriostatic agent which is sodium chloride, citric acid, glycine, acetic acid, alcohol or tea polyphenol. The medical humidification liquid having a bacteriostasis function is a safe and efficient reagent having no toxic and side effects and has good effects in oxygen humidification and clinical care. The medical humidification liquid having a bacteriostasis function has a simple formula and a low price, can be preserved easily, can kill and inhibit pathogenic bacteria and conditioned pathogens in an oxygen humidification liquid, has low replacement frequency, has good effects of disinfection and humidification, provides a comfortable patient oxygen inhalation environment after humidification, and improves clinical care work efficiency.

The invention relates to a healthy soap for inhibiting germ reproduction and preventing germ transmission and a preparation method thereof. Germs exist everywhere, and people can contact with germs at any time in the daily life; although most germs have no harm on the health of human beings, germs can result in a bad effect on human beings on specified conditions, namely conditioned pathogen, and even make people ill. The invention is a block healthy soap prepared with the method that corresponding minor ingredients are added into soap base, pancreatic enzyme, KF-88 and essence. The invention has the efficacy of disinfecting, sterilizing, decontaminating, quickly removing epidermis pathogenic bacterium (hepatitis virus, staphylococcus aureus and the like) and various kinds of reproduction, shack and infectious bacteria, effectively inhibiting various germs from reproducing and preventing germs transmission.

ACE receptors are affected in severe acute respiratory distress syndrome related coronaviruses. ACE genes are directly related to the morbidity and mortality of those with cystic fibrosis. The thick, sticky mucus in the respiratory, and digestive systems, is seen in the inherited disease cystic fibrosis. Viral induced sticky mucus in the respiratory and digestive systems can also be appreciated as a response to viral pathogens where the cycle of mucus production in vivo induces the recruitment of more mucus production to the extent that cellular damage occurs within the lower respiratory track requiring intubation as a life saving measure. In the most severe cases mechanical intubation fails due to the fact that no control over the recruitment of mucus production was achieved at the onset. SARS pathology shows inflammatory exudation in the alveoli and interstitial tissue, with hyperplasia of fibrous tissue and fibrosis. Inherited cystic fibrosis pathology shows atelectasis, mucoid impaction, acute and chronic inflammation, bronchiectasis, cyst formation, and fibrosis widespread. A virally induced disorder in relations to ACE2 receptors can be treated successfully at the early onset with inherited cystic fibrosis disease mimicking techniques with the efforts of minimizing the activity and utilization of the ACE2 receptor. Cystic fibrosis lung infections, and opportunistic pathogens contribute to chronic airway inflammation that is characterized by neutrophil/macrophage infiltration, cytokine release and ceramide accumulation. In terms of virally induced forms off ACE2 receptor pathologies, as it related to coronavirus such as Covid 19, presumably ceramide precursors which aid in intracellular transport of the virus into the cell via inflammation and remodeling is present in alveolar tissues of the lung in patients with cystic fibrosis while the same pathology occurs in patients with virally induced forms of ACE2 pathology which to often progresses to SARS or ARDS.

The invention belongs to the technical field of animal drugs and particularly relates to a preparation method of a spray reagent for preventing avian influenza of livestock and poultry. According to the spray reagent disclosed by the invention, a Chinese herbal probiotic preparation can protect respiratory mucosa and can be also used as a disinfectant for improving the environment of the livestockand poultry; the aim of disinfecting is achieved by using an antagonistic action of probiotics and metabolite thereof to pathogenic bacteria and conditioned pathogen. Chinese herbal medicines and theprobiotics have a synergistic effect, and further the capability of diffusion propagation of the avian influenza is weakened; in addition, the avian influenza is prevented and treated by a spray mode, so that the damage to liver and kidney caused by long-term administration is avoided.

The present invention relates to an antimicrobial composition for uracil non-secretory (URA−) bacteria, comprising uracil, uracil precursors, uracil analogs, or uracil-secreting opportunistic pathogens as an active ingredient; and a composition for preventing cell damage caused by uracil-secretory (URA+) bacteria, comprising ROS scavengers as an active ingredient. The present invention also relates to food or feed for antimicrobial activity and preventing cell damage, comprising said composition; a method for controlling dual oxidase (DUOX) activation, the generation of reactive oxygen species (ROS), or the level thereof; a method for producing cells, wherein DUOX activation, the generation of ROS, or the level thereof are controlled; and a method for providing information on gut pathogenicity in isolated bacteria. The composition of the present invention has effects for preventing symptoms caused by bacteria according to a mechanism which has been unknown in the art. Further, the present invention can be efficiently utilized for establishing prevention and treatment strategies for symptoms caused by bacteria later, as therapeutic strategies can be readily established by bacterial classification based on criteria that can be easily confirmed.

The invention discloses a composition containing schizophyllan and bifida yeast. The composition containing schizophyllan and bifida yeast is composed of the following raw materials by weight: 4-10 parts of schizophyllan, 2-8 parts of bifida ferment lysate, 0.4-1 part of an aloe vera extract, 1-10 parts of a hamamelis virginiana extract, 0.2-0.5 part of 1, 2-hexanediol, 0.2-0.5 part of p-hydroxyacetophenone and 65-85 parts of a dispersing agent. The composition disclosed by the invention has a function of regulating skin micro-ecological balance, and has good effects of conditioning various skin symptom diseases and repairing micro-damaged skin cells; the composition provided by the invention can effectively promote proliferation of skin resident probiotics, and has an inhibition effect onskin resident harmful bacteria and conditioned pathogens, so that probiotics are in a dominant position, and skin micro-ecological balance is promoted.

This invention describes a bacillus subtilis and the process for preparing its compound pharmaceutics. The bacillus subtilis is conserved at China General Microbiological Culture Collection Center of China Committee of Culture Collection for Microorganisms, the name is: Bacillus subtilis LY-35 and the conservation number is: CGMCC No. 1222. The pharmaceutics is a compound of the bacteriophages of such pathogens as bacillus subtilis, Staphylococcus, Streptocoaus, colibacillus, proteus, pseudomonas, salmonella, shigella, pasteurella and klebsiella. The pharmaceutics can prevent and treat the diseases caused by pathogens, and can be a non-polluted, high therapeutic effectiveness and safe substitute for antibiotics.

The invention discloses a composition based on brown algae extract and lactobacillus reuteri and application of the composition. The composition disclosed by the invention is prepared from the following components in parts by weight: 30 to 97 parts of brown algae extract and 3 to 70 parts of lactobacillus reuteri. The combination of the brown algae extract and the lactobacillus reuteri can promote field planting of the lactobacillus reuteri in intestinal tracts, and the field planting rate is remarkably increased. The combination of the brown algae extract and the lactobacillus reuteri can significantly reduce the fasting blood glucose and glycosylated hemoglobin concentration of type 2 diabetes model mice, improve the insulin secretion amount, significantly improve the abundance of beneficial bacteria such as bifidobacterium and lactobacillus in intestines, reduce the abundance of conditioned pathogenic bacteria such as enterococcus and proteobacteria. Good application prospects are realized.